Catabasis Pharmaceuticals Inc (NASDAQ:CATB)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CATB

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CATB

  • Market Cap$103.230m
  • SymbolNASDAQ:CATB
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS14875P2065

Company Profile

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted, a linker-drug discovery platform. The company's primary focus is on treatments for rare diseases. Its product pipeline includes CAT-1004, an oral small molecule for the treatment of Duchenne muscular dystrophy, CAT-2054 for the treatment of hypercholesterolemia and CAT-4001 which is used for the treatment of rare neurodegenerative diseases, such as Friedreich's ataxia and amyotrophic lateral sclerosis.Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's primary focus is on treatments for rare diseases.

Latest CATB news

Currently there for this company. Visit our news hub for other news .